Motivational Interviewing–Based Compliance/Adherence Therapy Interventions to Improve Psychiatric Symptoms of People With Severe Mental Illness: Meta-Analysis

Wong‐Anuchit, Choochart; Chantamit-o-pas, Chutima; Schneider, Joanne Kraenzle; Mills, Andrew C.

doi:10.1177/1078390318761790

Cited by 18 publications

(11 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Psychotropic medications are established first-line treatment for controlling psychiatric symptoms (Stern et al, 2018); however, nonadherence to prescriptions is common among people with SMI and the leading cause of relapse in mental illness (Barkhof et al, 2012). Systematic and meta-analytic research evidence supports the use of psychoeducation (Zhao et al, 2015), motivational interviewing (Wong-Anuchit et al, 2018), and behavioral strategies (Kreyenbuhl et al, 2016) to improve medication adherence for people with SMI.…”

Section: Discussionmentioning

confidence: 99%

Predicting Recovery in Individuals With Serious Mental Illness: Expanding the International Classification of Functioning, Disability, and Health (ICF) Framework

Sánchez

2020

Rehabilitation Counseling Bulletin

View full text Add to dashboard Cite

People with psychiatric disabilities experience significant impairment in fulfilling major life roles due to the severity of their mental illness. Recovery for people with serious mental illness (SMI) can be a long, arduous process, impacted by various biological, functional, sociological, and psychological factors which can present as barriers and/or facilitators. The purposes of this study were to: (a) investigate the International Classification of Functioning, Disability, and Health (ICF) framework’s ability to predict recovery in adults with SMI and (b) determine to what extent the ICF constructs in the empirical model explain the variance in recovery. Participants ( N = 192) completed a sociodemographic questionnaire and various measures representing all predictor and outcome variables. Results from hierarchical regression analysis with six sets of predictors entered sequentially (1 = personal factors-demographics, 2 = body functions-mental, 3 = activity-capacity, 4 = environmental factors, 5 = personal factors-characteristics, and 6 = participation-performance) accounted for 75% (large effect) of the variance in recovery. Controlling for all factors, by order of salience, higher levels of significant other support, education, executive function impairment, and social self-efficacy; primary, non-bipolar SMI diagnosis; greater resilience; lower levels of explicit memory-health impairment, affective self-stigma, and cognitive self-stigma; being younger; fewer self-care limitations; less severe psychiatric symptoms; and being unemployed and unmarried were found to significantly predict recovery. Findings support the validation of the ICF framework as a biopsychosocial recovery model and the use of this model in the development of effective recovery-oriented interventions for adults with SMI. Clinical and research implications are discussed.

show abstract

Section: Discussionmentioning

confidence: 99%

Predicting Recovery in Individuals With Serious Mental Illness: Expanding the International Classification of Functioning, Disability, and Health (ICF) Framework

Sánchez

2020

Rehabilitation Counseling Bulletin

View full text Add to dashboard Cite

show abstract

“…While this intervention showed some early promise for improving insight, adherence, attitudes towards medication and rehospitalisation rates in an inpatient sample (Kemp et al, 1996(Kemp et al, , 1998, further studies failed to replicate these positive findings for improving adherence (Barkhof et al, 2013;Byerly et al, 2005;O'Donnell et al, 2003), and a well-conducted, adequately powered RCT found adherence therapy to be ineffective in improving adherence, psychotic symptoms or quality of life in people with schizophrenia (Gray et al, 2006). Some evidence for efficacy has been provided by subsequent studies (Chien et al, 2019;Gray et al, 2016;Wong-Anuchit et al, 2019), although this generally relates to improving psychiatric symptoms rather than adherence directly.…”

Section: Interventions To Improve Adherencementioning

confidence: 99%

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

2019

View full text Add to dashboard Cite

These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, involving experts in schizophrenia and its treatment.They were asked to review key areas and consider the strength of the evidence on the risk-benefit balance of pharmacological interventions and the clinical implications, with an emphasis on meta-analyses, systematic reviews and randomised controlled trials where available, plus updates on current clinical practice. The guidelines cover the pharmacological management and treatment of schizophrenia across the various stages of the illness, including first-episode, relapse prevention, and illness that has proved refractory to standard treatment. It is hoped that the practice recommendations presented will support clinical decision making for practitioners, serve as a source of information for patients and carers, and inform quality improvement.

show abstract

“…When used by clinicians in a therapeutic interaction, MI is not the lone intervention and is often combined with other forms of therapeutic services to promote healthy behaviours (Wong‐Anuchit et al . 2018). Motivational interviewing could therefore be used to focus on exercise engagement and support consumers to increase motivation and behaviour change towards introducing exercise (Madson et al .…”

Section: Discussionmentioning

confidence: 99%

The perceptions of mental health clinicians integrating exercise as an adjunct to routine treatment of depression and anxiety

Garvey

Benson

Benger³

et al. 2022

Int J Mental Health Nurs

View full text Add to dashboard Cite

Individuals with depressive symptoms often experience changes in physical activity and lifestyle factors. Despite the benefits of exercise, mental health clinicians often do not refer for or prescribe exercise as part of traditionally accepted models of care for consumers with depression and anxiety. The aims were to investigate: (i) mental health clinicians' understanding of the relationship between exercise and mental health, (ii) if and how exercise is used by mental health clinicians in treatment for depression and anxiety, and (iii) the barriers to prescription of exercise. A descriptive qualitative method was used, and data were collected via individual semistructured interviews. Ten mental health clinicians with varying backgrounds participated in this study. The data driven inductive analysis of participants views identified three themes: (i) knowing and not knowing, (ii) consumer comorbiditiesthe risk and benefit dilemma, and (iii) protecting vulnerable consumers. Enhancing clinicians' knowledge of the beneficial role of exercise in treatment for consumers' experiencing depression and anxiety is an important step. Mental health services can support integration of exercise by implementing policies and training for staff to support exercise prescription, and the role and referral of exercise and physical activity specialists, as part of routine care to improve clinical outcomes for consumers. Additional considerations should be given to fiscal support to access exercise as an adjunct therapy.

show abstract

Motivational Interviewing–Based Compliance/Adherence Therapy Interventions to Improve Psychiatric Symptoms of People With Severe Mental Illness: Meta-Analysis

Abstract: These findings support the effectiveness of MI-based CAT interventions. Session length and dose effect should be considered when tailoring MI to clients.

Cited by 18 publications

References 35 publications

Predicting Recovery in Individuals With Serious Mental Illness: Expanding the International Classification of Functioning, Disability, and Health (ICF) Framework

Predicting Recovery in Individuals With Serious Mental Illness: Expanding the International Classification of Functioning, Disability, and Health (ICF) Framework

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

The perceptions of mental health clinicians integrating exercise as an adjunct to routine treatment of depression and anxiety

Contact Info

Product

Resources

About